85 results
DEF 14C
ATXI
Avenue Therapeutics Inc
18 Mar 24
Information statement
4:59pm
also maintain a website at www.avenuetx.com. You may access our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
bunionectomy patients to IV tramadol or IV morphine for pain relief administered during a 48-hour post-operative period. Patients will have access to IV
PRE 14C
ATXI
Avenue Therapeutics Inc
8 Mar 24
Preliminary information
4:31pm
at www.avenuetx.com. You may access our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
period. Of note, IV tramadol demonstrated safety and efficacy in this same surgical model in two Phase 3 efficacy trials. Patients will have access
DEF 14C
y61l0kn
29 Jan 24
Information statement
8:00am
PRE 14C
1g10ok1am1 aqofs2uok
17 Jan 24
Preliminary information
5:05pm
8-K
EX-99.1
mo2ig1p24d n7v2astz8
13 Nov 23
Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
4:10pm
8-K
EX-10.2
3ggb fa01
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
scwbap 5u
2 Nov 23
Prospectus supplement with pricing info
9:00am
8-K
EX-99.1
ph2ko286
10 Aug 23
Avenue Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:20pm